Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...

Asthma is one of the most common chronic diseases in India. In my practice, I see a pattern: most patients suffer not because asthma is untreatable, but because their everyday habits work quietly ...

The latest advances in asthma care combine revolutionary biologics, individualized immunotherapy, and targeted treatments that address specific triggers, ditching the “one-size-fits-all” approach. The ...

Medical experts are dismayed over a federal report's claim that kids are overprescribed asthma medications, saying it minimizes how many lives the drugs save. Safe treatment protocols for asthma ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...

What type of asthma inhaler is right for you? In the U.S., 25 million people are affected by asthma. That’s roughly 1 in 13 adults and children. Asthma can be mild or severe. Some people with asthma ...

As summer begins, Open Airways is reminding families that with consistent care, proper planning and continued medication use, ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...

The Asthma Society of Ireland is urging people with asthma and hay fever to take precautions as thunderstorms become possible ...

Asthma can strike at any age, and for many, winter brings seasonal triggers and increased vulnerability to respiratory ...

U.S. Rep. Kweisi Mfume (D-Md.-7) and Sen. Angela Alsobrooks (D-Md.) are teaming up on a new push to provide relief to those suffering from chronic lung conditions. Both members of Congress have put ...